Charles A. Kaufmann

4.2k total citations
45 papers, 2.2k citations indexed

About

Charles A. Kaufmann is a scholar working on Molecular Biology, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Charles A. Kaufmann has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Genetics and 12 papers in Psychiatry and Mental health. Recurrent topics in Charles A. Kaufmann's work include Genetic Associations and Epidemiology (14 papers), Schizophrenia research and treatment (7 papers) and 14-3-3 protein interactions (5 papers). Charles A. Kaufmann is often cited by papers focused on Genetic Associations and Epidemiology (14 papers), Schizophrenia research and treatment (7 papers) and 14-3-3 protein interactions (5 papers). Charles A. Kaufmann collaborates with scholars based in United States, Finland and Belgium. Charles A. Kaufmann's co-authors include Dolores Malaspina, Ming T. Tsuang, Jill Harkavy‐Friedman, C. Robert Cloninger, Stephen V. Faraone, Dragan M. Švrakić, Jack M. Gorman, T. Conrad Gilliam, Xavier Amador and Michael Krauthammer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and American Journal of Psychiatry.

In The Last Decade

Charles A. Kaufmann

45 papers receiving 2.1k citations

Peers

Charles A. Kaufmann
Ann E. Pulver United States
Gillian Spurlock United Kingdom
Paul R. Buckland United Kingdom
Ann E. Pulver United States
Ayman H. Fanous United States
Charles A. Kaufmann
Citations per year, relative to Charles A. Kaufmann Charles A. Kaufmann (= 1×) peers Sibylle G. Schwab

Countries citing papers authored by Charles A. Kaufmann

Since Specialization
Citations

This map shows the geographic impact of Charles A. Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles A. Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles A. Kaufmann more than expected).

Fields of papers citing papers by Charles A. Kaufmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles A. Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles A. Kaufmann. The network helps show where Charles A. Kaufmann may publish in the future.

Co-authorship network of co-authors of Charles A. Kaufmann

This figure shows the co-authorship network connecting the top 25 collaborators of Charles A. Kaufmann. A scholar is included among the top collaborators of Charles A. Kaufmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles A. Kaufmann. Charles A. Kaufmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krauthammer, Michael, Charles A. Kaufmann, T. Conrad Gilliam, & Andrey Rzhetsky. (2004). Molecular triangulation: Bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. Proceedings of the National Academy of Sciences. 101(42). 15148–15153. 125 indexed citations
2.
Malaspina, Dolores, Raymond R. Goetz, Jill Harkavy‐Friedman, et al.. (2001). Traumatic Brain Injury and Schizophrenia in Members of Schizophrenia and Bipolar Disorder Pedigrees. American Journal of Psychiatry. 158(3). 440–446. 95 indexed citations
3.
Kegeles, Lawrence S., Dikoma C. Shungu, Satish Anjilvel, et al.. (2000). Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Research Neuroimaging. 98(3). 163–175. 68 indexed citations
4.
Faraone, Stephen V., Joanne M. Meyer, Tara C. Matise, et al.. (1999). Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortion. American Journal of Medical Genetics. 88(6). 607–608. 13 indexed citations
5.
Malaspina, Dolores, Jill Harkavy‐Friedman, Charles A. Kaufmann, et al.. (1998). Psychobiological heterogeneity of familial and sporadic schizophrenia. Biological Psychiatry. 43(7). 489–496. 35 indexed citations
6.
Johnson, Janet Elise, Habibul Ahsan, Jill Harkavy‐Friedman, et al.. (1997). Anticipation in schizophrenia: Biology or bias?. American Journal of Medical Genetics. 74(3). 275–280. 23 indexed citations
7.
Brown, Alan S., et al.. (1996). Neurobiological Plausibility of Prenatal Nutritional Deprivation as a Risk Factor for Schizophrenia. The Journal of Nervous and Mental Disease. 184(2). 71–85. 75 indexed citations
8.
Prell, George D., Jack Peter Green, Ahmed Elkashef, et al.. (1996). The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients. Schizophrenia Research. 19(2-3). 171–176. 7 indexed citations
9.
Prell, George D., Jack Peter Green, Charles A. Kaufmann, et al.. (1995). Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophrenia Research. 14(2). 93–104. 105 indexed citations
10.
Alexander, Robert, et al.. (1994). Minor Physical Anomalies in Schizophrenia. The Journal of Nervous and Mental Disease. 182(11). 639–644. 51 indexed citations
11.
Malaspina, Dolores, et al.. (1994). Effects of pharmacologic catecholamine manipulation on smooth pursuit eye movements in normals. Schizophrenia Research. 13(2). 151–159. 11 indexed citations
12.
Jolkkonen, Jukka, Asla Pitkänen, Paavo Riekkinen, et al.. (1992). Somatostatin-like immunoreactivity in CSF of schizophrenic patients during haloperidol treatment. Biological Psychiatry. 31(9). 962–964. 2 indexed citations
13.
Malaspina, Dolores, et al.. (1992). Association of schizophrenia and partial trisomy of chromosome 5p. Schizophrenia Research. 7(2). 191–196. 16 indexed citations
14.
Stamm, Stefan, Diana Casper, Jonathan Dinsmore, et al.. (1992). Clathrin light chain B: gene structure and neuron-specific splicing. Nucleic Acids Research. 20(19). 5097–5103. 37 indexed citations
15.
Weeks, Daniel E., Thomas Lehner, Elizabeth Squires‐Wheeler, et al.. (1990). Measuring the inflation of the lod score due to its maximization over model parameter values in human linkage analysis. Genetic Epidemiology. 7(4). 237–243. 100 indexed citations
16.
Honer, William G., Charles A. Kaufmann, Joel E. Kleinman, Manuel F. Casanova, & Peter J. Davies. (1989). Monoclonal antibodies to study the brain in schizophrenia. Brain Research. 500(1-2). 379–383. 18 indexed citations
17.
Gilliam, T. Conrad, Nelson B. Freimer, Charles A. Kaufmann, et al.. (1989). Deletion mapping of DNA markers to a region of chromosome 5 that cosegregates with schizophrenia. Genomics. 5(4). 940–944. 39 indexed citations
18.
Kaufmann, Charles A.. (1988). Intracerebral Inoculation of Experimental Animals With Brain Tissue From Patients With Schizophrenia. Archives of General Psychiatry. 45(7). 648–648. 10 indexed citations
19.
Korpi, Esa R., Charles A. Kaufmann, Kirsi‐Marja Marnela, & Daniel R. Weinberger. (1987). Cerebrospinal fluid amino acid concentrations in chronic schizophrenia. Psychiatry Research. 20(4). 337–345. 62 indexed citations
20.
Kaufmann, Charles A., Dilip V. Jeste, Richard C. Shelton, et al.. (1986). Noradrenergic and neuroradiological abnormalities in tardive dyskinesia. Biological Psychiatry. 21(8-9). 799–812. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026